Abstract
The effects of kinins on the level of norepinephrine, dopamine, and serotonin and on their metabolites, i.e., normetanephrine, homovanillic acid, and 5-hydroxyindoloacetic acid in the brain tissue divided into cerebellum, corpus striatum, cortex, hippocampus, hypothalamus, medulla oblongata, and midbrain were investigated.
It was shown that bradykinin in a dose of 4 μg decreased the content of norepinephrine, in corpus striatum, midbrain, and cerebellum. It also decreased the level of dopamine in corpus striatum but increased the level of serotonin in corpus striatum and midbrain. Similar changes were observed with 100 U/kg of kallikrein.
It was that changed levels of investigated neuromediators are accompanied by changed levels of their metabolites. Bradykinin, in a dose of 4 μg, decreased the level of normetanephrine in corpus striatum, hippocampus, and midbrain and the level of homovanillic acid in corpus striatum, and increased the level of 5-hydroxyindoloacetic acid in corpus striatum and hippocampus.
It was also shown that bradykinin increased norepinephrine uptake by the blood platelets when its level in the platelets was low, and released the absorbed norepinephrine into the medium when the level of norepinephrine was higher.
The above results confirm the existence of an interaction of kinins with neuromediators, in the central nervous system.
Similar content being viewed by others
References
Abrams, W. B., Solomon, H. M.: The human platelet as a pharmacologic model for the adrenergic neuron. Clin. Pharmacol. Ther. 10, 702–709 (1969)
Andén, N. P., Ross, B. E., Werdinius, B.: The occurrence of domovanillic acid in brain and cerebrospinal fluid and its determination by a fluorimetric method. Life Sci. 2, 448–458 (1963)
Anton, A. H., Sayre, D. F.: Distribution of metanephrine and normetanephrine in various animals and their analysis in diverse biological material. J. Pharmacol. exp. Ther. 153, 15–19 (1966)
Barches, J., Usolin, E.: Serotonin and behavior New York-London: Academic Press 1973
Barthel, W., Haustein, K. O., Markwardt, F.: On the relations between serotonin uptake on function of the transport—ATPase system of blood platelets. Acta biol. med. germ. 31, 713–718 (1973)
Benetato, C. R., Bubuianu, E., Cirmaciu, R., Galesanu, E.: The action of bradykinin on the sympathic adrenergic centers. Rev. Roum. Physiol. 4, 245–250 (1967)
Bertolini, A., Mucci, P., Sternieri, E.: Behavioural effect of bradykinin injected into the cerebro-spinal fluid. Prostaglandins, peptides and amines. P. Montegazza and E. W. Hoston, eds. London-New York: Academic Press 1969
Braszko, J., Koscielak, M.: Effect of, kinins on the central action of serotonin. Pol. J. Pharmacol. Pharma. 27, Suppl. 61–68 (1975)
Ćapek, R.: Some effects of bradykinin on the central nervous system. Bioch. Pharmacol. 10, 61–64 (1962)
Ćapek, R., Masek, K., Sranka, M., Kirsisk M., Śvec, P.: The similarities of the angiotensin and bradykinin action on the central nervous system. Pharmacology 2, 161–170 (1969)
Glowinski, J., Iversen, L. L.: Regional studies of catecholamines in the rat brain—I. The disposition, of (3H) norepinephrine, (3H) dopamine and (3H) Dopa in various regions of the brain. J. Neurochem. 13, 655–669 (1966)
Glowinski, J., Kopin, I. J., Axelrod, J.: Metabolism of (3H) norepinephrine in the rat brain. J. Neurochem. 12, 25–30 (1965)
Gonzalez-Vegas, J. A.: Antagonism of dopamine—mediated inhibition in the nigro-striatal pathway, a mode of action of some catato—inducing drugs. Brain Res. 80, 219–228 (1974)
Graeff, F. G., Pelá, I. R., Rocha e Silva, M.: Behavioural and somatic effects of bradykinin injected into the cerebral ventricles of anesthetized rabbits. Brit. J. Pharmacol. 37, 723–732 (1969)
Haefely, W., Hürlimann, A., Thonen, H.: The effect of bradykinin and angiotensin on ganglionic transmission., In: E. G. Erdös, N. Back, and F. Sicuteri, eds., Hypotensive peptides, pp. 314–328. Berlin, Heidelberg, New York: Springer 1966
Haubrich, D. R., Denzer, J. S.: Simultaneous extraction and fluorometric measurement of brain serotonin, catecholamines, 5-hydroxyindoloacetic acid and homovanillic acid. Analyt. Biochem. 55, 306–312 (1973)
Heath, R. G.: Discussion. Ann. N.Y. Acad. Sci. 104, 311 (1963)
Herman, Z. S.: The effect of noradrenaline on rat's behaviour. Psychopharmacologia (Berl.) 16, 369–374 (1970)
Lambert, G. A., Lang, W. J.: The effects of bradykinin and eledoisin injected into the cerebral ventricles of conscious rats. Europ. J. Pharmacol. 9, 383–386 (1970)
Mannarino, E., Kirshner, N., Nashold, B. S.: The metabolism of (14C) noradrenaline by cat brain in vivo. J. Neurochem. 10, 373–379 (1963)
Moniuszko-Jakoniuk, J., Wiśniewski, K.: The effects of kinins on the psychomotor activity of rats as evaluated by Lat's test. Acta Neurobiol. exp. 34, 621–628 (1974)
Moniuszko-Jakoniuk, J., Wiśniewski, K., Bodzenta, A.: Effect of the activation of the kinin-forming system on the potency of chlorpromazine. Pharmacology 12, 216–223 (1974)
Schanberg, S. M., Schildkraut, J. J., Breese, G. R., Kopin, I. J.: Metabolism of normetanephrine—3H in rat brain—identification of conjugated 3-methoxy-4-hydroxyphenylglycol as the major metabolite. Biochem. Pharmacol. 17, 247–254 (1968)
Sharman, D. F.: Glycol metabolites of noradrenaline in brain tissue. Brit. J. Pharmacol. 36, 523–534 (1969)
Wiśniewski, K., Bodzenta, A.: Kinins and central effects of the acetylcholine. Acta Neurobiol. exp. 35, 85–92 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moniuszko-Jakoniuk, J., Wiśniewski, K. & Kościelak, M. Investigations of the mechanism of central action of kinins. Psychopharmacology 50, 181–186 (1976). https://doi.org/10.1007/BF00430490
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00430490